Loading...
Back to narrative

LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades

Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts

LXS logo
LXS
AnalystConsensusTarget
Not Invested
Published 22 Mar 2025
13 viewsusers have viewed this narrative update

Update shared on 21 Jan 2026

Fair value Decreased 8.10%
Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-50.4%
7D
-15.5%

Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return.

Analyst Commentary

Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.

Bearish Takeaways

  • Bearish analysts have cut price targets into a €15 to €17 range, which sits below our updated fair value estimate of about €18.66 and signals concern about LANXESS' ability to fully execute on its plans in the current sector backdrop.
  • The move to an Underweight rating from some analysts reflects a view that risk and reward are not balanced, with questions around earnings visibility and the pace of any potential improvement in profitability.
  • One research house expresses a negative view on European chemicals and ingredients overall, which weighs on sentiment for LANXESS and suggests that any company specific progress could still be constrained by wider sector pressures.
  • Preference for other areas such as industrial gases, ingredients and distributors suggests that some analysts see better growth and execution prospects elsewhere, which can limit multiple expansion for LANXESS even if fundamentals stabilize.

Valuation Changes

  • The fair value estimate was reduced from about €20.30 to roughly €18.66, implying a moderately lower central value for the shares in the model.
  • The discount rate moved slightly higher from about 7.86% to roughly 8.15%, reflecting a somewhat higher required return applied to future cash flows.
  • Revenue growth was adjusted down from about 1.09% to roughly 0.82%, pointing to more cautious assumptions around the top-line outlook.
  • The net profit margin was held broadly unchanged at about 5.22%, indicating no material shift in long-run profitability assumptions in the current model.
  • The future P/E was trimmed from roughly 6.89x to about 6.44x, suggesting a slightly lower valuation multiple applied to expected earnings.

Have other thoughts on LANXESS?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.